Dash Bio, Inc.

New Filing

CIK: 0002041370·Other Health Care·DELAWARE·Filed: Jul 14, 2026

Total Offering

$30,000,022

Amount Sold

$30,000,022

Investors

9

First Sale

Jun 15, 2026

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Year Incorporated: 2024
Non-Accredited Investors: No

Related Persons

Name	Role
David Johnson
Alexander Tallett
Andy Smith

Company

56 BROAD STREET

BOSTON, MA, 02109

617-249-4472

SEC Filing

0002041370-26-000003

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.